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a  b  s t  r a  c t
Rapid  eye movement (REM) sleep or  paradoxical  sleep is  an elusive  behavioral  state.  Since  its discovery  in
the  1950s,  our knowledge  of  the  neuroanatomy,  neurotransmitters  and neuropeptides  underlying  REM
sleep regulation  has  continually evolved  in parallel  with  the  development  of novel technologies.  Although
the  pons was initially  discovered  to be  responsible  for REM sleep, it  has  since been  revealed  that  many
components  in the  hypothalamus,  midbrain, pons, and  medulla also  contribute to REM  sleep.  In this
review, we first provide  an  up-to-date  overview of REM sleep-regulating  circuits  in the  brainstem  and
hypothalamus  by  summarizing  experimental  evidence  from  neuroanatomical, neurophysiological  and
gain-  and  loss-of-function  studies. Second,  because quantitative approaches are  essential  for  understand-
ing  the  complexity  of REM sleep-regulating  circuits  and because  mathematical  models have  provided
valuable  insights  into the dynamics underlying REM sleep genesis  and  maintenance,  we  summarize
computational studies  of the  sleep-wake  cycle,  with  an emphasis  on REM sleep  regulation.  Finally, we
discuss  outstanding  issues  for  future  studies.
© 2018 The Authors.  Published  by  Elsevier B.V. This is an open  access article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Brain states vary from moment to  moment throughout the day.
Humans typically cycle between three major behavioral states:
wakefulness, rapid eye movement (REM) sleep and non-REM
(NREM) sleep, with additional stages of NREM sleep. REM and
NREM sleep have distinct characteristics. For example, NREM sleep
is characterized by  slow, large-amplitude fluctuations of cortical
electroencephalograms (EEGs) whereas REM sleep is characterized
by fast, small-amplitude fluctuations of EEGs. Although these sleep
states are closely related with each other with respect to neural
mechanisms and functions (Brown et al., 2012; Hobson and Pace-
Schott, 2002;  Pace-Schott and Hobson, 2002; Scammell et al., 2017;
Stickgold et al., 2001; Weber and Dan, 2016), this review article
particularly focuses on the mechanisms underlying REM sleep.
REM sleep is associated with vivid dreaming, rapid eye
movement, muscle atonia and other body homeostatic signa-
tures. Electrophysiological characteristics of REM sleep include
desynchronized cortical EEG, hippocampal theta waves and ponto-
geniculo-occipital (PGO) waves (Aserinsky and Kleitman, 1953;
Brown et al., 2012; Dement and Kleitman, 1957; Jouvet, 1962;
Luppi et al., 2012; Peever and Fuller, 2017; Scammell et al., 2017;
Weber and Dan, 2016; Callaway et al., 1987; Datta, 1997). REM sleep
is also known as “paradoxical sleep” because the desynchronized
EEG observed during REM sleep resembles that during wakeful-
ness, but without muscle tone (Jouvet et al., 1959). REM sleep also
contains phasic and tonic periods: phasic periods are characterized
by bursts of rapid eye movements whereas no rapid eye move-
ments occur during tonic periods (Wehrle et al., 2007; Moruzzi,
1963). Although detailed characteristics (e.g., REM sleep duration,
eye movements) vary across species, birds and lizards also exhibit
similar electrophysiological features of REM sleep, suggesting that
REM sleep evolved in  a common ancestor early in amniote evolu-
tion (Low et al., 2008; Monnier, 1980; Siegel, 1995; Joiner, 2016;
Shein-Idelson et al., 2016).
The sleep stage with REM and desynchronized EEG activity
was  originally discovered in  humans in the 1950s (Aserinsky and
Kleitman, 1953;  Dement and Kleitman, 1957), and subsequently
confirmed in cats (Dement, 1958). Jouvet et al. comprehensively
described the main characteristics of REM sleep and established
the notion that the pons is responsible for REM sleep (Jouvet, 1962;
Jouvet and Michel, 1959).
Since these landmark studies, with the advent of technological
advancements, our understanding of the neurobiology underlying
REM sleep regulation has expanded considerably. In the late  1950s
and 60s, lesion, electrophysiological and pharmacological experi-
ments identified the brainstem structures and neurotransmitters
responsible for REM sleep (Jouvet, 1962). In the 70s, unit recording
experiments identified brainstem neurons which are exclusively
active (REM-on) or silent (REM-off) during REM sleep in  cats
(McCarley and Hobson, 1971; Hobson et al., 1975; Jouvet, 1972).
Subsequently, as novel approaches ranging from Fos mapping and
juxtacellular recording to recent genetic and molecular technolo-
gies have been adopted, various hypothalamic and brainstem nuclei
have been identified to contribute to REM sleep (Boissard et al.,
2002;  Hassani et al., 2009; Krenzer et al., 2011; Lu et al., 2006b;
Luppi et al., 2017; Scammell et al., 2017; Weber et al., 2015; Weber
and Dan, 2016;  Brown et al., 2012).
Trends in choice of animal models have also changed (Fig. 1):
Although the cat model initially dominated the field, the use of rats
Fig. 1. Publication records on REM sleep research. The number of publication
records on REM sleep was extracted from the PubMed database for each animal
species. The publication records of computational studies on  sleep-wake cycle were
also extracted (‘model’).
had become increasingly popular until the 2000s. This is  probably
due to their smaller size and the development of anatomical, histo-
chemical and electrophysiological methods. Over the past decade,
the use of mice has rapidly gained momentum due to  the revo-
lution of molecular genetic approaches for systems-level studies,
such as viral tracing, optogenetics and chemogenetics. While there
is no doubt that mice will soon become a  dominant species in  this
field, it should be also noted that REM sleep has been confirmed in
different species including the Pogona dragons (Shein-Idelson et al.,
2016), indicating the importance of comparative studies.
In  addition to animal studies, computational/mathematical
studies of sleep-wake cycles have also made important contri-
butions to  this field since the pioneering studies by McCarley
and Hobson (1975) and Borbely (1982). Given the complexity of
sleep regulatory circuits, such quantitative approaches will become
increasingly essential. Indeed, there has been an upward trend of
publication records over the past two decades (Fig. 1).
In the present review, we summarize the current status of our
understanding of REM sleep regulation, with a  focus on the cir-
cuit mechanisms and computational models. First, we summarize
the current understanding of key brain regions and neuropeptides
within REM sleep-regulating circuits. Second, we cover a range of
computational models to explain the sleep-wake cycle. Finally, we
discuss outstanding issues and future challenges in this field. Read-
ers should also refer to other review articles (Brown et al., 2012;
Luppi et al., 2013a; Peever and Fuller, 2017; Saper et al., 2010;
Scammell et al., 2017; Weber and Dan, 2016).
2. REM sleep-regulating circuits
REM sleep-regulating circuits are  widespread throughout the
brainstem (midbrain, pons, and medulla) and the hypothalamus
and involve a  range of neurotransmitters and neuropeptides. In this
section, we survey the literature on key components of REM sleep-
regulating circuits within the brainstem and hypothalamus (Fig. 2).
2.1. Brainstem REM sleep-regulating circuits
Research on brainstem REM sleep-regulating circuits has a
long history since pioneering studies by Jouvet and his colleagues
(Jouvet and Michel, 1959; Jouvet, 1962). Despite numerous efforts
over the past six decades, a  comprehensive picture of brainstem
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Fig. 2. Diagram of REM sleep-regulating circuits. Brainstem and hypothalamic areas described in the main text are shown, with a  simplified view of activity during REM
sleep as well as connectivity. DMH, dorsomedial hypothalamus; DpMe, dorsal part of the deep mesencephalic reticular nuclei; DRN, dorsal raphe nucleus; eVLPO, extended
area  of the ventrolateral preoptic area; GiA, alpha gigantocellular nucleus; GiV, ventral gigantocellular nucleus; LC, locus coeruleus; LDT, laterodorsal tegmental nucleus; LPGi,
lateral paragigantocellular nucleus; MCH, melanin concentrating hormone neurons; OH, orexin/hypocretin neurons; PPT, pedunculopontine tegmental nucleus; RMg, raphe
magnus; RPA, nucleus raphe pallidus; SLD, sublaterodorsal nucleus; vlPAG, ventrolateral periaqueductal gray. Glu, glutamate; ACh, acetylcholine; GABA, -aminobutyric
acid;  Gly, glycine.
REM sleep-regulating circuits is  still lacking. Here we focus on the
key brainstem nuclei involved in  REM sleep regulation, by summa-
rizing their 1) anatomical features, 2) neural activity during REM
sleep and 3) gain- and loss-of-function studies.
2.1.1. Sublaterodorsal nucleus
The sublaterodorsal (tegmental) nucleus (SLD) in rodents has
long been implicated in  REM sleep genesis and muscle atonia (Luppi
et al., 2006, 2012; Luppi et al., 2017; Scammell et al., 2017).
Anatomy. The SLD is located immediately ventral from the peri-
aqueductal gray (PAG) and corresponds to the rostral part of the
subcoeruleus nucleus. It is  equivalent to the peri-locus coeruleus
alpha (peri-LC) in the cat (Sakai et al., 1979, 2001)  and is com-
posed of glutamatergic, GABAergic and cholinergic neurons (Sakai
et al., 2001; Boissard et al., 2002).
The SLD receives glutamatergic inputs from the lateral and ven-
trolateral PAG (vlPAG), the primary motor cortex, the bed nucleus
of the stria terminalis (BNST) and the central nucleus of the amyg-
dala. It also receives GABAergic inputs from the mesencephalic,
pontine reticular nuclei and to  a  lesser extent the parvicellular retic-
ular nucleus and contralateral SLD (Boissard et al., 2003; Lu et al.,
2006b). Although a recent study with a  cell-type-specific tracing
approach confirmed the projection from vlPAG GABAergic neurons
onto glutamatergic neurons in the SLD (Weber et al., 2018), input
specificity onto each SLD  cell-type remains to be  fully characterized.
SLD glutamatergic neurons project rostrally to the intralaminar
nuclei of the thalamus, posterior hypothalamus, and basal fore-
brain (BF), and caudally to  glycinergic neurons in the raphe magnus
(RMg), ventral and alpha gigantocellular nuclei (GiA and GiV) and
the lateral paragigantocellular nucleus (LPGi). These rostral and
caudal projections are  thought to be responsible for cortical desyn-
chronization and muscle atonia, respectively (Sakai et al., 1979;
Jones, 1991a; Boissard et al., 2002).
Activity. SLD glutamatergic neurons are primarily REM-on,
meaning that they are more active during REM sleep compared
to non-REM (NREM) sleep and wakefulness (Sakai, 1985; Sakai and
Koyama, 1996; Lu  et al., 2006b; Clement et al., 2011). It has been
repeatedly shown that  SLD glutamatergic neurons strongly express
Fos after prolonged REM sleep in rats and mice (Clement et al.,
2011; Krenzer et al., 2011). Although SLD GABAergic neurons have
been initially reported to  be  REM-on (Lu et al., 2006b), a  subsequent
report does not support this observation (Sapin et al., 2009). SLD
cholinergic neurons do not appear to  be REM-on based on Fos map-
ping (Verret et al., 2005) although an extracellular recording study
demonstrated that  a  subpopulation of SLD cholinergic neurons are
active during both REM sleep and wakefulness (Sakai, 2012). Thus,
although the SLD has been implicated in REM sleep genesis, future
studies need to reconcile the heterogeneity of state-dependent and
cell-type-specific firing within the SLD.
Function. Pharmacologically GABAa antagonists (bicuculine or
gabazine) and glutamate agonist can induce REM sleep (Boissard
et al., 2002; Xi et al., 1999; Onoe and Sakai, 1995), suggesting that
tonic glutamatergic barrage and the removal of a  tonic GABAergic
tone can cause REM sleep. In contrast, cholinergic agonist (carba-
chol) induces REM when injected into the cat peri-LC, but not in
all cases when applied to the rat SLD (Boissard et al., 2002; Bourgin
et al., 1995; Deurveilher et al., 1997; Gnadt and Pegram, 1986;
Shiromani and Fishbein, 1986; Velazquez-Moctezuma et al., 1989).
Given the contradictory results of cholinergic effects on REM sleep
induction, further studies are  necessary to quantitatively deter-
mine how the balance between different transmitter inputs onto
SLD neurons can contribute to REM sleep induction.
Furthermore, a recent chemogenetic study demonstrated that
glutamatergic neurons in the rostrolateral SLD (“Atoh1-E10.5-
medial cells”) promote NREM sleep and inhibit REM sleep (Hayashi
et al., 2015). These glutamatergic neurons project to GABAer-
gic neurons in  the deep mesencephalic reticular nucleus (DpMe),
which negatively regulate REM sleep, possibly inhibiting REM
sleep-promoting neurons in the SLD. Therefore, REM sleep-
regulating circuitry within the SLD is  more complex than previously
appreciated.
The SLD also plays a  causal role in muscle atonia. A focal lesion
of the SLD or the deletion of glutamate signaling induces a  REM
sleep-like state, but without muscle atonia, thus implicating aber-
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rant glutamatergic transmission in REM sleep behavioral disorder
(Krenzer et al., 2011; Lu et al., 2006b). A prominent explanatory
mechanism of muscle atonia is  that because SLD glutamatergic
neurons project to glycinergic/GABAergic neurons in the ventral
medulla (vM), which in turn inhibit spinal motor neurons, the
removal of SLD excitatory inputs onto vM cannot induce muscle
atonia (Boissard et al., 2002; Luppi et al., 2017; Lu  et al., 2006b).
However, as we discuss below, distinct vM circuits have been
implicated in REM sleep regulation and muscle atonia. Therefore,
detailed circuit analysis between the SLD and vM is  still required.
Furthermore, the role of SLD GABAergic neurons is also unclear.
2.1.2. Ventrolateral periaqueductal gray and deep mesencephalic
reticular nucleus
The ventrolateral periaqueductal gray (vlPAG) together with the
adjacent dorsal part of the deep mesencephalic reticular nucleus
(DpMe) has been implicated in  gating REM sleep by  receiving inputs
from the hypothalamus and other brainstem structures (Luppi et al.,
2013a; Petitjean et al., 1975).
Anatomy. The vlPAG is a part of the large midbrain structure, the
PAG, and is located ventrolaterally within the caudal section of the
PAG. vlPAG neurons are composed of glutamatergic, GABAergic and
dopaminergic (DA) neurons. vlPAG DA neurons are often referred
as to the dorso-caudal extension of the A10 group, which includes
DA neurons in the dorsal raphe nucleus (DRN) (Cho et al., 2017;
Dougalis et al., 2012; Hokfelt et al., 1984).
The vlPAG is an anatomical hub of REM sleep regulatory cir-
cuits within the brainstem. vlPAG neurons receive inputs from
the forebrain, hypothalamus and brainstem, such as the central
nucleus of amygdala, the zona incertia (ZI), the nucleus accum-
bens, the lateral hypothalamus, the lamina terminalis including
the median preoptic nucleus (MnPO), the extended part of the
ventrolateral preoptic nucleus (eVLPO), SLD, peduncluopontine
tegmental nucleus/laterodorsal tegmental nucleus (PPT/LDT), and
the vM (Boissard et al., 2003; Burgess et al., 2013; Clement et al.,
2012; Hsieh et al., 2011; Liu et al., 2017; Uschakov et al., 2007,  2009;
Weber et al., 2015; Zhang et al., 2013; Lu et al., 2006b).
Both GABAergic and non-GABAergic vlPAG neurons project to
the SLD (Boissard et al., 2003; Weber et al., 2018) while GABAer-
gic neurons also strongly innervate the DRN (Gervasoni et al.,
2000) and the locus coeruleus (LC) (Weber et al., 2018). DA neu-
rons have reciprocal connections with the medial prefrontal cortex,
ventrolateral preoptic nucleus (VLPO), orexin/hypocretin neurons,
LDT cholinergic neurons, and LC  noradrenergic neurons (Lu et al.,
2006a).
Activity. REM-on and –off neurons are intermingled within the
vlPAG and the DpMe, which reflects the complex nature of anatom-
ical properties described above. While the majority of GABAergic
neurons are REM-off, a  subset of GABAergic neurons are also REM-
on  (Lu et al., 2006b; Sapin et al., 2009; Weber et al., 2018). REM-off
neurons have been suggested to suppress SLD glutamatergic neu-
rons during wakefulness and NREM sleep to prevent muscle atonia
and REM sleep induction (Lu et al., 2006b).
Function. The functional role of vlPAG neurons in  REM sleep
was  first suggested with a  lesion study carried out by Jouvet and
his colleagues (Petitjean et al., 1975). While neurotoxic lesions in
the vlPAG and DpMe promote REM sleep (Lu  et al., 2006b), musci-
mol (GABAa agonist) application increases REM sleep in both cats
(Sastre et al., 1996) and rats (Sapin et al., 2009). Furthermore, opto-
genetic activation of vlPAG GABAergic neurons suppresses REM
sleep generation (Weber et al., 2015,  2018).  As described above,
GABAergic neurons in  the DpMe receive inputs from glutamatergic
neurons located in the rostrolateral SLD. Chemogenetic activa-
tion of DpMe GABAergic neurons inhibit REM sleep and promote
NREM sleep, whereas chemogenetic silencing enhances REM sleep
(Hayashi et al., 2015). These results are consistent with the notion
that REM-off neurons located within the vlPAG and DpMe suppress
REM sleep.
The function of REM-on neurons, however, remains elusive.
Optogenetic stimulation of vlPAG GABAergic neurons can inhibit
REM-on GABAergic neurons (Weber et al., 2018), suggesting intrin-
sic connections between REM-on and –off GABAergic neurons
(Sapin et al., 2009; Weber et al., 2018). It has been proposed that
REM-on GABAergic neurons in vlPAG can be activated by choliner-
gic inputs, resulting in the suppression of DRN serotonergic neurons
(Yang and Brown, 2014). These results suggest that REM-on and
REM-off GABAergic neurons in  the vlPAG play antagonistic roles in
REM sleep regulation.
vlPAG DA neurons are wake-promoting (Lu et al., 2006a), but the
functional role of vlPAG glutamatergic neurons remains unclear.
In addition, because the vlPAG receives inputs from the amygdala
(Burgess et al., 2013) and has long been implicated in  both  fear-
associated defensive behaviors and pain (Behbehani, 1995; Tovote
et al., 2016), the relationship between anxiety/fear and sleep would
be an interesting topic to explore.
2.1.3. Ventral medulla
The functional role of the ventral medulla (vM) in REM sleep
and muscle atonia has been actively debated (Luppi et al., 2012,
2006;  Luppi et al., 2017; Sapin et al., 2009; Lu et al., 2006b; Weber
et al., 2015). Accumulating evidence suggests that vM neurons play
distinct roles in REM sleep and muscle atonia depending on circuits
as summarized below.
Anatomy. The vM is located within the ventrocaudal portion
of the brainstem. It includes the raphe magnus (RMg), ventral and
alpha gigantocellular nuclei (GiA and GiV) and the lateral paragi-
gantocellular nucleus (LPGi), and other nuclei. GiA, GiV and RMg
are located ventromedially within the vM,  thus they are collectively
known as the ventromedial medulla (vmM). Within the vM,  diverse
cell types are  intermingled (Holmes and Jones, 1994; Leger et al.,
2009;  Rampon et al., 1996): while glutamatergic and GABAergic
neurons are widely distributed, many GABAergic neurons are colo-
calized with glycine. Tyrosine hydroxylase positive neurons and a
dense cluster of cholinergic neurons can be  found in the LPGi and
the nucleus ambiguus, respectively. Serotonergic neurons can be
found in  the RMg  (B3 cell group) and the nucleus raphe pallidus
(RPA) (B1 cell group).
The vM receives inputs from the spinal cord, medulla, pons, mid-
brain, hypothalamus, amygdala, and cortex (Sirieix et al., 2012;
Van Bockstaele et al., 1989; Andrezik et al., 1981). Of these,
GABA/glycinergic neurons receive strong glutamatergic inputs
from the SLD (Fort et al., 2009; Luppi et al., 2013b).
GABA and/or glycine containing neurons in the vmM strongly
innervate spinal motor neurons (Holstege, 1991;  Holstege and
Bongers, 1991). On  the other hand, the LPGi project to the solitary
tract, parabrachial nucleus, and Ko¨lliker-Fuse nucleus (Guyenet and
Young, 1987; Sirieix et al., 2012). LPGi GABAergic neurons provide
inputs to the LC (Ennis and Aston-Jones, 1989; Sirieix et al., 2012).
Interestingly, distinct populations of GABAergic neurons within the
vM project rostrally to the vlPAG and caudally to the spinal cord
(Weber et al., 2015) although the exact distribution of these pop-
ulations within the vM remains unclear. Serotonergic cell groups
(B1 and B3) in the vM also project to diverse areas, including the
spinal cord, Ko¨lliker-Fuse nucleus, LDT, SLD, LC, inferior colliculus,
part of the thalamus, hypothalamus, BF and hippocampus (Loewy
et al., 1981).  Detailed cell type-specific projections, including glu-
tamatergic, cholinergic, and aminergic projections, remain to be
explored.
Activity. GiV GABAergic neurons are REM-on in  both cats (Siegel
et al., 1979)  and rodents (Maloney et al., 2000; Sapin et al., 2009).
An enhanced Fos expression was observed following recovery from
REM sleep deprivation in  GiV, GiA and RMg  GABAergic/glycinergic
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neurons, but to  a lesser extent in the LPGi (Valencia Garcia
et al., 2018). Indeed, LPGi GABAergic neurons show diverse fir-
ing responses including REM-on, REM-off, and other types (Sirieix
et al., 2012). A recent optogenetic tagging study (Weber et al., 2015)
showed that firing rates of vM GABAergic neurons increase grad-
ually over ∼30 s before the NREM to  REM transition and abruptly
decrease at the end of REM sleep. Non-GABAergic neurons, on the
other hand, respond with an increase in  firing ∼10 s before the
onset of REM sleep and a gradual decrease at  the termination of
REM sleep. Many of these non-GABAergic neurons were most active
during running or moving. RPA serotonergic neurons are REM-off
(Heym et al., 1982). Thus, the composition of REM-on and –off
neurons vary across nuclei and cell types within the vM.
Function. The functional role  of vM neurons in REM sleep induc-
tion and muscle atonia has been actively debated (Fort et al., 2009;
Luppi et al., 2013b; Valencia Garcia et al., 2018; Weber et al., 2015;
Lu et al., 2006b). For example, GiV neurons have long been impli-
cated in muscle atonia by  receiving strong glutamatergic inputs
from the SLD and co-releasing GABA and glycine onto spinal motor
neurons (Luppi et al., 2012; Fort et al., 2009; Luppi et al., 2013b).
However, lesioning the vM has had no effect on muscle atonia (Lu
et  al., 2006b).  Weber and his  colleague (Weber et al., 2015) recently
demonstrated the causal role of the vM in REM sleep regulation,
rather than muscle atonia: optogenetic activation of vM GABAer-
gic neurons induces and prolongs REM sleep and chemogenetics
inhibition of vM GABAergic neurons reduces REM sleep quantities.
Another recent study specifically targeted the vmM  (GiV, GiA and
RMg) to demonstrate that genetic inactivation of vmM GABAer-
gic/glycinergic neurons does not  affect sleep architecture including
REM sleep, but suppresses muscle atonia (Valencia Garcia et al.,
2018). Thus, if the optogenetic/chemogenetic study (Weber et al.,
2015) primarily targeted the LPGi, rather than the vmM,  it is prob-
able that vmM  and LPGi inhibitory neurons may  play distinct roles
in muscle atonia and REM sleep, respectively. Further investigation
to reconcile these observations is required.
2.1.4. Pedunculopontine tegmental nucleus and laterodorsal
tegmental nucleus
The pedunculopontine tegmental nucleus (PPT) and laterodor-
sal tegmental nucleus (LTD) are a brainstem cholinergic system
and have long been implicated in  REM sleep, arousal and corti-
cal desynchronization (McCarley, 2007; Mena-Segovia and Bolam,
2017; Scammell et al., 2017; Weber and Dan, 2016). Although pon-
tine cholinergic neurons were originally thought to play a causal
role in REM sleep induction, the exact role of the PPT/LDT in  REM
sleep remains to  be determined fully (Grace and Horner, 2015;
Grace, 2015; Kroeger et al., 2017; Van Dort et al., 2015).
Anatomy. The PPT and LDT are located within the caudal
cholinergic column (Ch5 and Ch6) and contain a heterogeneous
population of  cholinergic, glutamatergic and GABAergic neurons
(Clements and Grant, 1990; Wang and Morales, 2009; Ford et al.,
1995). Subpopulations of these cell classes expressed calcium-
binding proteins (calbindin, calretinin, and parvalbumin) and
they are heterogeneously distributed within the PPT (Martinez-
Gonzalez et al., 2012).
The PPT/LDT receives inputs from diverse areas of the brain,
including the cortex, thalamus, hypothalamus, pons, cerebellum,
medulla, spinal cord and the basal ganglia (Semba and Fibiger,
1992; Saper and Loewy, 1982; Martinez-Gonzalez et al., 2011).
Within the brainstem, DRN and LC neurons project to the PPT (Jones
and Yang, 1985; Vertes, 1991), with preferential projection from
DRN serotonergic neurons to non-cholinergic neurons (Steininger
et al., 1997).
Both cholinergic and non-cholinergic axonal projections have
been traced at the single cell resolution (Martinez-Gonzalez et al.,
2011; Mena-Segovia and Bolam, 2017; Mena-Segovia et al., 2008).
Outputs include, but are not limited to the thalamus, basal ganglia,
BF, hypothalamus, LC, pontine reticular formation, ventral tegmen-
tal area (VTA), SLD and DRN (Cornwall et al., 1990;  Ford et al., 1995;
Luppi et al., 1995; Martinez-Gonzalez et al., 2011; Mena-Segovia
and Bolam, 2017; Semba et al., 1990). Interestingly, the topograph-
ical organization of ascending cholinergic innervation was also
described (Mena-Segovia and Bolam, 2017):  rostral PPT choliner-
gic neurons preferentially innervate motor-related areas, such as
the basal ganglia, whereas LDT cholinergic neurons preferentially
innervate limbic-related areas, such as the VTA.
Activity. Different cell types show distinct state-dependent
firing patterns: cholinergic neurons are most active during wake-
fulness and REM sleep, whereas glutamatergic and GABAergic
neurons appear to be maximally active either during wake, REM
sleep or during both wake and REM (Datta and Siwek, 2002;
Steriade et al., 1990; el Mansari et al., 1989; Cox et al., 2016;
Boucetta et al., 2014; McCarley and Hobson, 1971). Consistent with
these findings, Fos mapping studies have also shown that both
cholinergic and GABAergic neurons are active during REM sleep
in  both cats and rats (Verret et al., 2005; Maloney et al., 1999;
Torterolo et al., 2001).
Function. There is  an ongoing debate on the functional role
of the PPT/LDT in the initiation and maintenance of REM sleep.
Lesion (Petrovic et al., 2013; Shouse and Siegel, 1992; Webster
and Jones, 1988; Sastre et al., 1981)  and pharmacological (Boissard
et al., 2002; Gnadt and Pegram, 1986; Deurveilher et al., 1997;
George et al., 1964; Amatruda et al., 1975; Baghdoyan et al., 1984;
Coleman et al., 2004; Pollock and Mistlberger, 2005)  studies have
provided inconsistent and contradictory results. Recently, chemo-
genetic activation of PPT neurons was performed (Kroeger et al.,
2017): glutamatergic activation increases the duration of wakeful-
ness, while GABAergic activation moderately reduces the duration
of REM sleep. Consistent with pharmacological studies (Boissard
et al., 2002; Grace et al., 2014), chemogenetic activation of cholin-
ergic neurons has no effect on REM sleep, but promotes light NREM
sleep. On  the other hand, electrical stimulation of LDT neurons
increases the number of REM sleep bouts (Thakkar et al., 1996). Sim-
ilarly, optogenetic activation of PPT/LDT cholinergic neurons during
NREM sleep promotes REM sleep (Van Dort et al., 2015). While the
current consensus is that PPT/LDT neurons play a  modulatory role
in  REM sleep generation (Grace and Horner, 2015), state-dependent
coordination of PPT/LDT neuronal firing and its influence on down-
stream nuclei (e.g., SLD and vlPAG) and REM sleep induction need
to be fully explored.
2.1.5. Locus coeruleus
Norepinephrine (NE)-producing neurons are located across
brainstem nuclei with diverse populations projecting to numer-
ous regions. Of particular interest is  the LC, which is one of the
most intensively investigated brainstem nuclei in terms of  devel-
opmental origin, molecular profiles, anatomical connectivity, and
physiological and pathophysiological functions (Aston-Jones and
Cohen, 2005; Robertson et al., 2013; Schwarz and Luo, 2015).
Anatomy. The LC  is located in  the dorsal region of the caudal
pons, lateral to the LDT and dorsal to the caudal part of  the SLD
in  mice. All LC neurons produce NE by converting from DA using
dopamine-beta-hydroxylase (Dbh). Neuropeptide galanin is also
expressed in  the majority (up to 80%) of LC  neurons (Holets et al.,
1988; Robertson et al., 2013). Two  morphological classes of  LC  neu-
rons, multipolar and fusiform cells, have been described in the rat
(Grzanna and Molliver, 1980;  Swanson, 1976). Thus, although all LC
neurons are NE-producing, they are not necessarily homogeneous.
LC  neurons receive inputs from other arousal systems and
project widely throughout the CNS (Kebschull et al., 2016; Luppi
et al., 1995; Schwarz and Luo, 2015; Schwarz et al., 2015). Recently,
the anatomical input-output relationship of LC-NE neurons was
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comprehensively characterized by using advanced viral tracing
approaches (Schwarz et al., 2015). LC-NE neurons projecting to
diverse brain regions receive inputs from similar areas. Thus, they
integrate information from, and broadcasts to, many brain regions.
However, there is also specificity. For example, medulla-projecting
LC-NE neurons receive disproportionally smaller input from the
central amygdala than other LC-NE neurons. Although LC neurons
were previously thought to be  the only source of NE projections to
the  cortex, NE neurons from other brainstem nuclei also project to
the  cortex (Robertson et al., 2013). In the context of REM sleep reg-
ulation, LC-NE neurons receive strong GABAergic inputs from the
vlPAG, and both the dorsal and lateral paragigantocellular nuclei
(DPGi and LPGi), which contain REM-on neurons (Gervasoni et al.,
2000; Luppi et al., 2017; Verret et al., 2006).
Activity and function.  LC neurons are  generally REM-off
(Aghajanian and VanderMaelen, 1982; Aston-Jones and Bloom,
1981; Hobson et al., 1975; McGinty and Harper, 1976). Thus, they
promote arousal and play an antagonistic role in  REM sleep. While
LC-NE activity correlates with pupil diameter during wakefulness
(Aston-Jones and Cohen, 2005),  LC-NE neurons are virtually silent
during REM sleep. Indeed, the pupil size during REM sleep is mini-
mum  (Yuzgec et al., 2018).
NE inhibits PPT/LDT cholinergic neurons (Luebke et al., 1992;
Williams and Reiner, 1993)  and pharmacological enhancement of
NE transmission suppresses REM sleep (Gervasoni et al., 2002;
Jones, 1991b; Jones et al., 1969). However, optogenetic inhibition
of LC neurons did not alter REM sleep (Carter et al., 2010). These
conflicting observations may  be reconciled in the future by char-
acterizing the remaining NE containing brainstem nuclei (i.e., A1,
A2, A5, A7, LC and subcoeruleus). Indeed, a  moderate number of
NE neurons (A1 and A2) displayed Fos expression after the recov-
ery of REM deprivation, suggesting that non-LC NE neurons may
be important for REM sleep regulation (Leger et al., 2009). Thus, in
addition to detailed anatomical study across these nuclei, the exact
role of brainstem NE neurons in  REM sleep regulation still need to
be fully characterized.
2.1.6. Dorsal raphe nucleus
Serotonergic (5-HT) neurons can be found in  the raphe nuclei,
of which the dorsal raphe nucleus (DRN) (B5 cell group) is  the
largest serotonergic nucleus (Dahlstrom and Fuxe, 1964; Jacobs and
Azmitia, 1992). The role of serotonin in sleep was originally pro-
posed by Jouvet (Jouvet, 1972). However, it has since been shown
that DRN serotonergic neurons are wake-promoting and suppress
REM sleep, similar to LC-NE neurons (McGinty and Harper, 1976;
Trulson and Jacobs, 1979). Nevertheless, because of the diversity
of cell types within the DRN as well as serotonin receptors across
brain regions, the role  of serotonin in sleep remains elusive.
Anatomy. The DRN is located in  the midline of the brainstem,
ventral to the cerebral aqueduct, occupying the ventral part of the
PAG. The DRN neurons are composed of serotonergic, glutamatergic
and GABAergic neurons, many of which also express a  variety of
neuropeptides, such as galanin and substance P (Monti, 2010b). A
subset of serotonergic neurons also co-release glutamate (Fischer
et al., 2014). There is  a  small population of DA neurons in the DRN
(Cho et al., 2017; Dougalis et al., 2012; Hokfelt et al., 1984).
The DRN receives GABAergic inputs from multiple regions, such
as the BF, hypothalamus, substantia nigra, VTA, ventral PAG, ros-
tral pontine reticular nucleus, and dorsal gigantocellular nucleus
(Gervasoni et al., 2000; Luppi et al., 2008). DRN neurons also receive
inputs from neurons releasing a variety of neurotransmitters and
neuropeptides, such as histamine, DA, NE, ACh, orexin/hypocretin
and melanin-concentrating hormone (MCH) (Panula et al., 1988;
Sakai et al., 1977; Beckstead et al., 1979; Saavedra et al., 1976;
Woolf and Butcher, 1989; Lee et al., 2005a; Hervieu et al., 2000;
Kilduff and de Lecea, 2001).
DRN neurons innervate a  wide range of areas, including the cere-
bral cortex, amygdala, BF, thalamus, preoptic and hypothalamic
areas, LC, and pontine reticular formation (Imai et al., 1986; Peyron
et al., 1998a). Based on the distribution of cell types and anatomical
projections, six subdivisions of the DRN have been proposed in rats
(Lowry et al., 2008; Monti, 2010b).
Activity. Although the majority of 5-HT neurons are  active dur-
ing  wake and virtually inactive during REM sleep (McGinty and
Harper, 1976; Trulson and Jacobs, 1979), heterogeneity of their
firing has been reported in cats, rats and mice (Allers and Sharp,
2003;  Hajos et al., 1995; Sakai and Crochet, 2001; Urbain et al.,
2006;  Sakai, 2011). For  example, a  fourth of the DRN  neurons are
sleep-active and around one-fifth are  active during both wakeful-
ness and REM sleep in  mice. They are topographically organized
(Sakai, 2011). DRN-DA neurons were observed to be most active
during wakefulness (Cho  et al., 2017).
Function. Pharmacological studies indicate that GABAergic
inputs to the DRN play a  key role in  REM induction (Gervasoni
et al., 2000; Nitz and Siegel, 1997). GABA concentrations in
the DRN increase during REM sleep and pharmacological activa-
tion/inactivation of GABAa receptors increases and decreases REM
sleep, respectively. GABAergic neurons in the vlPAG, DPGi and LPGi
seem to provide the source of these GABAergic inputs.
While DRN DA neurons can induce arousal (Cho et al., 2017), the
serotonergic effects on REM sleep are complex, depending on the
expression and location of receptor subtypes (Monti, 2010a): for
example, 5-HT1A receptor expressing DRN 5-HT neurons inhibit
adenylate cyclase. The administration of 5-HT1A agonists into the
DRN reduces 5-HT concentration and enhances REM sleep (Portas
et al., 1996). On the other hand, 5-HT1A receptor also expresses
in downstream PPT/LDT cholinergic neurons. Microinjection of 5-
HT1A receptor agonists into the LDT suppresses REM sleep (Monti
and Jantos, 2004). Thus, serotonergic effects on REM sleep are site-
specific.
In summary, although it is widely thought that most seroto-
nergic neurons are wake-promoting and REM-sleep-inhibiting, the
exact roles of DRN neurons in  sleep are still elusive. Because sero-
tonin and sleep are closely related with depression, further studies
on DRN neurons would be relevant from both basic scientific and
clinical viewpoints.
2.2. Hypothalamic REM sleep-regulating circuits
The hypothalamus consists of highly heterogeneous cell popu-
lations (Romanov et al., 2017)  and contributes to diverse biological
functions including sleep related functions, such as the circa-
dian rhythm, the stabilization of the sleep-wake cycle, and REM
sleep regulation. In particular, a wide range of neuropeptides play
a  role in sleep regulation (Steiger and Holsboer, 1997). Recent
genetic-based circuit studies have significantly contributed to the
advancement in  this topic. In this section, we  summarize the
1) molecular features, 2) anatomical features, 3) neural activity
during REM sleep, and 4) gain- and loss-of-function studies, of
three neuropeptidergic systems within the hypothalamus (Fig. 2):
orexin/hypocretin, melanin-concentrating hormone (MCH), and
galanin.
2.2.1. Orexin/hypocretin
Hypothalamic orexin/hypocretin (OH) neurons heavily inner-
vate REM sleep-suppressing brainstem regions, including the LC,
DRN, and vlPAG. A deficit in  this system results in  narcolepsy, with
pathological intrusion of REM sleep, called cataplexy. Thus, this
system is crucial for the physiological regulation of REM sleep by
stabilizing wakefulness.
Molecular features. OH is a  neuropeptide, consisting of  orexin A
(hypocretin 1) and orexin B (hypocretin 2) derived from a  common
C. Héricé et al. /  Neuroscience Research 140 (2019) 77–92 83
precursor peptide, prepro-orexin (de Lecea et al., 1998; Sakurai
et  al., 1998). OH can activate two G-protein-coupled receptors,
OX1R and OX2R (Sakurai et al., 1998). The former has greater affin-
ity for orexin A than orexin B whereas the latter has similar affinity
for both types. OX1R is coupled to the Gq/11 to activate phospho-
lipase C whereas OX2R is coupled to both Gq/11 and Gi.
Anatomy. OH neurons are exclusively located in the lateral
hypothalamus (LH) and posterior hypothalamus (PH). They coex-
press dynorphin, galanin, prolactin, neuronal activity-regulated
pentraxin and glutamate (Chou et al., 2001; Risold et al., 1999;
Abrahamson et al., 2001; Tsujino and Sakurai, 2009). Many OH neu-
rons also express vesicular glutamate transporters, but not GAD67,
suggesting that they are also glutamatergic (Rosin et al., 2003).
OH neurons receive inputs from the lateral parabrachial nucleus,
VLPO, medial and lateral preoptic areas, BF, posterior/dorsomedial
hypothalamus, VTA, and median raphe nuclei (Sakurai et al., 2005;
Yoshida et al., 2006). OH neurons also receive inputs from Lhx6-
positive GABAergic neurons in the zona incerta (ZI) (Liu et al., 2017).
OH neurons widely project to  various regions (Peyron et al.,
1998b): in addition to innervating areas within the hypothalamus,
the densest projection can be found in  the LC. OH neurons also
project to the septal nuclei, BNST, the paraventricular and reuniens
nuclei of the thalamus, ZI, subthalamic nucleus, PGA (includ-
ing vlPAG), substantia nigra, DRN, parabrachial area, PPT/LDT,
medullary reticular formation, inferior colliculus, and the nucleus
of the solitary tract. The expression pattern of OXRs is generally
consistent with the innervation pattern of OH neurons. The distri-
bution of OX1R and OX2R is partially overlapped, implying distinct
functional roles (Trivedi et al., 1998; Marcus et al., 2001; Lu  et al.,
2000b).
Activity. OH neurons are generally REM-off. They discharge
during active wakefulness and decrease their firing during quiet
wakefulness, but still respond to sensory stimulation. They are
silent during sleep including both NREM and REM sleep (Hassani
et al., 2009; Lee et al., 2005b; Mileykovskiy et al., 2005).
Function. Although OH neurons receive inputs from various
wake-promoting neurons, their effects on OH neuronal activity are
complex. For example, carbachol and histamine have excitatory
effects on OH neurons (Brown et al., 2002; Sakurai et al., 2005)
whereas serotonergic neurons have inhibitory effects (Muraki et al.,
2004; Sakurai et al., 2005). Effects of noradrenergic neurons are
mixed (Carter et al., 2012; Yamanaka et al., 2006; Hara  et al., 2001).
OH neurons are inhibited by a  subset of GABAergic neurons (Lhx6+)
in the ventral ZI to  induce NREM sleep (Liu et al., 2017).
OH activates monoaminergic systems, including LC-NE, VTA-DA,
DRN-5-HT, and histaminergic cells (Yamanaka et al., 2002; Brown
et al., 2002; Hagan et al., 1999; Nakamura et al., 2000), consistent
with the notion that OH plays a  causal role in arousal (Adamantidis
et al., 2007). However, the effects of OH on cholinergic neurons
depend on the cholinergic nucleus. For instance, orexin A injected
into the LDT increases the time spent in wakefulness and decreases
the time spent in REM sleep (Xi et al., 2001). Orexin A induces exci-
tation of cholinergic neurons in  the LDT (Takahashi et al., 2002) and
BF (Eggermann et al., 2001). On the other hand, orexin A can indi-
rectly inhibit PPT cholinergic neurons by  activating PPT GABAergic
interneurons as well as GABAergic neurons in  the substantia nigra
pars reticulata (Takakusaki et al., 2005).
Effects of OH neuron activation on MCH  neurons are generally
inhibitory, but can also be excitatory (Apergis-Schoute et al., 2015;
van den Pol et  al., 2004; Hassani et al., 2009). The inhibitory effect
of OH cells on MCH  neurons is probably due to the recruitment of
local GABAergic neurons via OH activation, but not glutamatergic
or dynorphinergic effects (Apergis-Schoute et al., 2015).
In summary, findings are generally consistent with the notion
that OH neurons play a role in the stabilization of wakefulness by
interacting with other wake/sleep-promoting neurons. However,
detailed synaptic and circuit mechanisms remain to be  fully char-
acterized. In  addition, although the OH system plays a  causal role  in
narcolepsy (Pintwala and Peever, 2017; Sakurai, 2007; Thannickal
et al., 2000; Peyron et al., 2000; Lin et al., 1999; Chemelli et al., 1999;
Tsujino and Sakurai, 2009), the cause of narcolepsy is  still unclear.
2.2.2. Melanin-concentrating hormone
While OH neurons stabilize wakefulness, melanin-
concentrating hormone (MCH) neurons have the opposite effect
on the regulation of sleep-wake states by increasing REM and
NREM sleep.
Molecular features. MCH was first discovered in  fish (Kawauchi
et al., 1983; Rance and Baker, 1979) and later in the mammalian
brain (Vaughan et al., 1989; Nahon et al., 1989). MCH  is produced
from a preproprotein, called prepro-MCH, which also encodes
neuropeptide-glutamic acid-isoleucine (NEI) and neuropeptide-
glycine-glutamic acid (NGE). MCH  is a 19-amino acid neuropeptide
and binds to G-protein-coupled receptors, termed MCHR1 (or
GPR24) and MCHR2. As MCHR1 is  coupled with Gai/o and Gaq
proteins, MCHR1 activation causes a  strong inhibition of neurons
(Hawes et al., 2000). MCHR2 gene shows species differences: in
rodents (the rat, mouse, hamster, and guinea pig) and rabbits,
MCHR2 is a  pseudogene, thus non-functional whereas in carnivores
(the dog and ferret) and primate (rhesus macaque and human),
MCHR2 is functional and expressed in the brain (such as the claus-
trum) (Tan et al., 2002). MCHR2 is  coupled to Gq  proteins, which
trigger intraceullular signaling. However, the function of MCHR2
remains unknown.
Anatomy. MCH neurons are primarily located in the LH and ZI.
The distribution of MCH  neurons shows sexually dimorphic pat-
terns in  rats. For example, MCH  neurons can be  found in the LDT  of
female but not male rats (Rondini et al., 2007). Some MCH  neurons
co-express GAD67 and others express vGluT1 (Jego et al., 2013;
Harthoorn et al., 2005).
Anatomical inputs to MCH neurons has been characterized com-
prehensively (Gonzalez et al., 2016). Of numerous brain regions, the
following areas provide strong innervation to MCH  neurons: the
tuberal nucleus and the periventricular, the lateral, ventromedial
and dorsomedial hypothalamic nuclei within the hypothalamus;
the nucleus accumbens, BNST, and BF within the cerebral nuclei;
and the midbrain reticular nucleus, PAG and VTA within the mid-
brain.
MCH  neurons project to areas throughout the brain. In  particu-
lar, they heavily innervate the LH, medial septum, medial diagonal
band, lateral part of the medial mammillary nucleus, and PPT
(Bittencourt et al., 1992).
Activity. A  Fos mapping study demonstrated that MCH  neu-
rons are strongly active during REM sleep (Verret et al., 2003).
This was subsequently confirmed with electrophysiology, whereby
MCH neurons were observed to fire exclusively during REM sleep
in  rats (Hassani et al., 2009). Thus, contrary to OH neurons, MCH
neurons are REM-on.
Function. Consistent with these observations, intracerebroven-
tricular injection of MCH  increases both NREM and REM sleep in
a  dose dependent manner (Verret et al., 2003). Similarly, when
administered into the DRN, vlPAG and LC, MCH  also increases the
time spend in  REM sleep, with a moderate increase in  NREM when
injected into the DRN (Lagos et al., 2009; Fujimoto et al., 2017;
Monti et al., 2015). Furthermore, MCHR1 antagonist administration
decreases REM and NREM sleep (Ahnaou et al., 2008). However, an
increase in REM sleep episodes was  observed in MCHR1 knock-
out mice, suggesting that compensatory mechanisms are at play
(Adamantidis et al., 2008).
A series of optogenetic studies have shed new light on the func-
tion of MCH neurons (Konadhode et al., 2013; Tsunematsu et al.,
2014; Jego et al., 2013). Although detailed approaches and optical
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stimulation protocols varied across reports, all three independent
studies confirmed that the activation of MCH  neurons increases the
time spent in REM sleep. A  chemogenetic study also confirmed a
similar effect (Vetrivelan et al., 2016). On  the other hand, varied
optogenetic experimental parameters have also resulted in  incon-
sistent effects being observed. For example, Jego and colleagues
only observed increases in REM sleep duration with 20 Hz optical
stimulation at the onset of REM sleep, but not with 1 Hz stimula-
tion. Another recent study showed that optogenetic activation of
MCH  neurons increases both REM and NREM sleep at night (active
period), but only increases REM sleep during the light period (inac-
tive period) (Blanco-Centurion et al., 2016).
Optogenetic silencing of MCH  neurons did not affect sleep archi-
tecture (Tsunematsu et al., 2014; Jego et al., 2013). Although genetic
ablation of MCH  neurons also had no effect on the total duration of
REM sleep, the chronic deletion of MCH neurons altered the diurnal
rhythm (Tsunematsu et al., 2014; Vetrivelan et al., 2016). Overall,
MCH  neurons play a regulatory role in REM sleep and probably
NREM sleep too. However, given the activity pattern of MCH  neu-
rons across the sleep-wake cycle (∼ 1 Hz, not 20 Hz, during REM
sleep), it is still unclear how MCH  neurons modulate REM sleep-
regulating circuits.
2.2.3. Galanin
Galanin (GAL) is a  neuropeptide expressed widely in the brain
and peripheral tissue. While GAL has been implicated in  the reg-
ulation of numerous physiological functions, GAL-positive (GAL+)
neurons in the hypothalamus have been found to play a role in
sleep regulation. However, the exact function of GAL +  neurons in
sleep remains uncertain. Here, we summarize the basic molecu-
lar and anatomical features of GAL and GAL receptors, and then
focus on the function of hypothalamic GAL +  neurons in REM sleep
regulation.
Molecular features. GAL consists of 29 amino acids (Tatemoto
et al., 1983) (30 amino acids in  humans). GAL is produced from
a 123-animo acid precursor, which is  encoded by the GAL gene
(Crawley, 1995). Three G-protein-coupled GAL receptors have been
identified: GALR1 and GALR3 inhibit adenylyl cyclase whereas
GALR2 stimulates phospholipase C and increases intracellular inos-
itol triphosphate turnover (Lang et al., 2007; Branchek et al., 2000;
Smith et al., 1998; Fathi et al., 1997; Habert-Ortoli et al., 1994).
Anatomy. GAL is  widely expressed in  the central nervous sys-
tem, with strong expression in  the hypothalamus, medulla, and
spinal cord (Merchenthaler et al., 1993; Skofitsch and Jacobowitz,
1986; Melander et al., 1986). In the telencephalon, GAL + neurons
can be found in the BNST, BF, and central nucleus of amygdala. In the
pons, the DRN and LC  also contain a  large number of GAL +  neurons.
GALRs are also widely expressed, but show distinct expression pat-
terns (Mennicken et al., 2002; Kolakowski et al., 1998; O’donnell
et al., 1999; Parker et al., 1995), suggesting diverse functions of
GAL.
Hypothalamic GAL +  neurons are primarily GABAergic, but a
recent study identified distinct sub-populations based on single-
cell RNA sequencing analysis (Romanov et al., 2017). Although
beyond the scope of this review, a subset of cholinergic neurons in
the BF also expresses GAL, implicating a  role in arousal and memory
(Miller et al., 1998; Melander et al., 1985).
Activity and function. Although GAL administration does not
promote REM sleep (Toppila et al., 1995), GAL + neurons play a  role
in REM sleep regulation. Neurons extending dorsally and medi-
ally from the VLPO (called the extended VLPO, eVLPO) have been
implicated in REM sleep regulation (Lu et al., 2000a; Koyama and
Hayaishi, 1994; Szymusiak et al., 1998; Lu  et al., 2002). Saper and
his colleagues demonstrated that REM sleep duration is  correlated
with the number of Fos + neurons in the eVLPO - a majority of which
are GAL-positive (Lu et al., 2002). eVLPO neurons project to both
REM-on/-off regions, including the vlPAG, LDT, DRN  and LC (Lu
et al., 2006b, 2002). GAL inhibits LC  neurons (Seutin et al., 1989),
suggesting REM sleep-promoting effects.
GAL +  neurons in the dorsomedial hypothalamus (DMH) also
regulate REM sleep (Chen et al., 2018). Interestingly, DMH
GAL +  neurons projecting to the preoptic area are REM-off and
optogenetic activation of these neurons suppress REM sleep. The
preoptic area also contains MCH  neurons. On the other hand, DMH
GAL +  neurons projecting to  the RPA in the vM are  REM-on and
optogenetic activation of these neurons promote REM sleep. Char-
acterizing anatomical and functional interactions between two
distinct GAL + neurons within the DMH  would be interesting.
Thus, GAL +  neurons can promote and inhibit REM sleep
depending on implemented circuits. Further comprehensive
anatomical and functional characterization will clarify the role of
GAL +  neurons in REM sleep. In addition, because GAL expression
itself can be changed by responding to anatomical lesions or REM
sleep deprivation (Toppila et al., 1995; Cortes et al., 1990), the
dynamic regulatory mechanism of GAL expression is  also an impor-
tant issue.
3. Computational models of  REM sleep
The wake-sleep cycle is regulated by complex interactions
between at least three fundamental processes: a  homeostatic pro-
cess, a  circadian process, and an ultradian process. Computational
models of sleep-wake cycles typically incorporate at least one of
these processes. The main purpose of these computational mod-
els can be (1) to replicate the dynamics of sleep-wake cycles with
and without perturbations, such as sleep deprivation and pharma-
cological manipulations, (2) to  replicate the dynamics of neural
population activity in sleep/wake regulating circuits, and (3) to
explain the relationship between specific neural systems and dis-
ease states, such as the relationship between OH neurons and
narcolepsy. The level of implementation varies across models, from
the more conceptual model to the more detailed neural network
models with varied architectures and formalizations. In this sec-
tion, we provide a  brief overview of the computational models of
the sleep-wake cycle, with an emphasis on REM sleep. We  begin
by introducing Borbely’s two-process model (Fig. 3A) to  provide a
broad context of this topic. We  will then focus on computational
models of REM sleep regulation which include two major categories
of models - the reciprocal interaction (RI) model and the mutual
inhibition (MI) model (also known as the flip-flop switch model)
(Figs. 3B and C). Finally, we  briefly summarize integrative models
which contain various brain structures. Readers may also refer to
other reviews (Weber, 2017; Borbely and Achermann, 1992; Booth
and Diniz Behn, 2014).
3.1. Two-process model
Borbely’s two-process model offers a conceptual framework of
sleep-wake cycles (Borbely, 1982). In  this model, a  homeostatic
sleep-dependent process (Process S) and a circadian process (Pro-
cess C) play a  dominant role in sleep regulation (Fig. 3A). Process
S  reflects the global changes in cortical slow wave activity (SWA)
as a biomarker. Process C can be explained by the activity of  the
suprachiasmatic nucleus (SCN) (Welsh et al., 2010). Total sleep
propensity is represented by the difference between the Processes
S  and C. After quantitative implementation of this concept (Daan
et al., 1984), the two-process model was  further extended with an
external function to trigger REM sleep (Achermann and Borbely,
1990). Computational models over the last decade have imple-
mented this model with detailed network architectures to reflect
experimental observations. For  example, Phillips and Robinson
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Fig. 3. Computational models of sleep-wake cycles and REM sleep.
(A)  Two-process model (modified from Borbély 1982). Sleep is  regulated by  a  homeostatic mechanism (Process S) and a  circadian mechanism (Process C).  Total sleep
propensity is represented by the difference between the Processes S  and C.
(B)  An elementary component of a Reciprocal Interaction (RI) model.
(C)  An elementary component of a  Mutual Inhibition (MI) model. A homeostatic/circadian drive contribute to shifting states.
(D)  An example of an integrative model (modified from Tamakawa et al., 2006). BS, brainstem; BF, basal forebrain; DR, dorsal raphe nucleus; LC, locus coeruleus; MnPN,
median preoptic nucleus; PFH, perifornical hypothalamus; TMN, tuberomammillary nucleus; VLPO, ventrolateral preoptic area; 5 H  T,  serotonin; Ach, acetylcholine; GABA,
gamma  aminobutyric acid; HA, histamine; NA, noradrenaline; OH, orexin/hypocretin.
have implemented the two-process model in  several neural net-
work models which uses different neural population firing rate
formalisms (Robinson et al., 2011; Phillips and Robinson, 2008,
2007). In the following sections, we focus on computational models
of REM sleep regulation.
3.2. Reciprocal interaction model
The RI model consists of an excitatory REM-on population inter-
acting with an inhibitory REM-off population (Fig. 3B). The first of its
kind was produced by  McCarley and Hobson with REM-on neurons
in the pontine cholinergic field interacting with REM-off neurons
in the LC (McCarley and Hobson, 1975). A predator-prey inter-
action model with Lotka-Volterra equations was utilized in  this
model, whereby the activity of REM-off neurons (predator) gradu-
ally decays due to self-inhibition, which results in increased activity
of REM-on neurons (prey). Although this model mimicked the time
course of neural firing of REM-on and REM-off neurons, it was too
sensitive to perturbations and did not include the circadian rhythm.
Subsequently, the original model was extended by introducing a
limit cycle as well as circadian variation (McCarley and Massaquoi,
1986). This limit cycle reciprocal interaction model (LCRIM) was
applicable to human sleep data as well as for a  simulation of
pharmacological experiments. An integrated model was further
developed to generate qualitatively realistic sleep-wave cycles by
linking the two-process model with the LCRIM (Massaquoi and
McCarley, 1992).
Recent models incorporated the dynamics of the RI model into
a more physiologically based model (Booth et al., 2017; Behn
and Booth, 2012; Diniz Behn and Booth, 2010; Behn et al., 2007;
Tamakawa et al., 2006), which we summarize in the section
below. Although the original model was inspired by  excitatory
and inhibitory interactions between cholinergic and monoamin-
ergic systems, experimental evidence (discussed above) over the
last decade suggests that this reciprocal interaction may  not  be
sufficient for REM sleep generation.
3.3. Mutual inhibition model
The MI  model (or flip-flop switch model) consists of mutual
inhibitory interactions between REM-on and REM-off neurons
(Fig.  3C). The original model was conceptually proposed for wake-
sleep regulation where sleep-promoting VLPO GABAergic neurons
and wake-promoting monoaminergic neurons mutually inhibit
each other. The wake stabilizing effects of OH neurons were also
represented as a ‘finger’ of the flip-flop switch (Saper et al., 2001).
Later, Lu and his colleagues extended this concept to  REM-NREM
regulation by experimentally demonstrating inhibitory REM-on
and REM-off neurons within the brainstem (Lu  et al., 2006b). Since
then, several computational models incorporated this mutual inhi-
bition into their network architecture (Grace et al., 2014; Dunmyre
et al., 2014; Kumar et al., 2012; Rempe et al., 2010; Behn and Booth,
2012).
In  this model, mutually inhibiting components provide a
bistable feedback loop. Because a  key feature of this circuit is
self-reinforcing to stabilize a particular state, additional inputs to
inhibitory components play a  key role in  shifting the balance of
mutual inhibition, that is,  state change. Such inputs can reflect cir-
cadian and/or homeostatic drives. However, the neural basis of such
drives remains unknown.
Of recent models, Booth and her colleagues developed a  simple,
but elegant dynamical system model to implement this MI  model
with their neural population firing rate and neurotransmitter for-
malism (Dunmyre et al., 2014). By coupling two flip-flop switches
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together, the model could capture rat sleep behavior including
recovery after REM sleep deprivation.
Although most models have been developed as a population fir-
ing rate model with varied formalisms, a  network model with leaky
integrate-and-fire model neurons was also developed in order to
assess the effect of muscarinic receptor anatagonism on REM-on
subcoeruleus activity (Grace et al., 2014). In this model, MI  between
REM-on and –off neurons within the vlPAG was implemented with
a ramping input to REM-off neurons. A  similar network model with
the large number of model neurons needs to be developed to fully
capture the dynamics of sleep-wake cycles, not  just the transition
from NREM to REM sleep.
3.4. RI model versus MI  model
What is the similarity and difference between the RI and MI
models? How do each of these network motifs respond to pertur-
bations? Which motif plays a primary causal role for REM sleep
transitions? Although answers to  these questions remain unclear,
these issues were addressed by Diniz Behn and her colleagues
(Behn et al., 2013). By using minimal RI and MI  models with varied
implementations of homeostatic drive, they identified conditions
for the generation of REM-NREM sleep cycles and investigated the
robustness of REM-NREM sleep cycles by analyzing the response
of model dynamics to manipulation of synaptic interactions and
self-modulatory inputs.
The RI model results in stable limit cycle oscillations rather than
a single fixed point, meaning that continuous state shifts are inher-
ited in this system. On the other hand, the MI  model stabilizes the
brain state. In contrast to  the RI model, extrinsic inputs or param-
eter change are required to change the state within the MI  model.
Thus, the homeostatic drive plays a crucial role in REM-NREM sleep
cycles in the MI  model. These results suggest that the neuronal
populations associated with the causal REM sleep network may  be
identified by evaluating distinct responses in  REM sleep dynam-
ics to experimental modulation of specific network components.
The combination of experimental approaches with these types of
computational studies will be helpful to interpret the dynamics of
REM-on and REM-off neural firing as well as the effect of perturba-
tions (e.g., optogenetics) on REM-NREM sleep cycles.
3.5. Integrative models
While computational models for REM sleep can be conceptu-
ally categorized into two major categories, researchers have also
developed integrative models that  include various brain regions
in accordance with experimental observations. For example,
Tamakawa et al (2006) developed an ambitious integrative model
consisting of 10 subcortical nuclei across the BF, hypothalamus and
brainstem, which can be categorized into four functional units:
sleep-active, wake-active, REM-active (REM-on), and wake-REM-
active groups (Fig. 3D). Despite the large number of parameters, this
‘quartet’ network successfully reproduced the dynamics of neu-
ral firing in each component across sleep-wake cycles (Tamakawa
et al., 2006). Subsequently, different neural network models have
been developed with varied network architectures and mathemat-
ical formalisms (Grace et al., 2014; Kumar et al., 2012; Rempe et al.,
2010;  Behn and Booth, 2012; Diniz Behn and Booth, 2010; Behn
et al., 2007; Booth and Diniz Behn, 2014). As new experimental dis-
coveries are made, such integrative models should be also updated.
To date, at least two approaches are missing in this field: first, there
are few computational models that implement the effects of opto-
genetic stimulation on REM sleep regulation (Carter et al., 2012).
Second, a large-scale realistic network model with spiking model
neurons has not been developed to the best of our knowledge.
4. Conclusion and future directions
In  summary, REM sleep-regulating circuits are widely dis-
tributed across the brainstem and hypothalamus, utilizing diverse
neurotransmitters and neuropeptides. Thus, REM sleep-regulating
circuits are a highly robust and complex system. While exper-
imental findings are still fragmented and mostly qualitative, it
is crucial to understand this complexity quantitatively by incor-
porating advanced technologies with computational modeling. In
particular, computational models reflecting the latest experimental
evidence are urgently required, together with quantifying anatom-
ical/synaptic connections as well as characterizing the dynamics
of neural ensembles in  the hypothalamus and brainstem in  a  cell
type-specific fashion.
To better understand REM sleep, at least five key questions
remain to be addressed: the first issue is  to determine the evolu-
tionary origin of REM sleep. Given the complexity and redundancy
of the regulatory circuit, it is not surprising that the primitive
elements of REM sleep can be found in lower vertebrates (Shein-
Idelson et al., 2016). Although adult mice have been a popular
choice as an animal model, further comparative (Joiner, 2016)
and developmental studies (Hayashi et al., 2015; Robertson et al.,
2013)  will help shed new light on the mechanism underlying REM
sleep regulation. Advanced anatomical methods, lineage tracing,
and genome engineering may  play an important role to this end.
The second issue is  to dissect the anatomical complexity of
REM sleep-regulating circuits at various levels. For example, what
neurotransmitters and neuropeptides are utilized? How many cell
types are contributing to REM sleep regulation? How are they
anatomically connected in a  cell-type-specific manner? Advanced
genetic and single-cell profiling technologies, as well as the latest
anatomical methods should be  applied to  address these  questions
(Weber and Dan, 2016). In addition, in vitro slice experiments will
add quantitative information about synaptic connections.
The third issue is to determine the neural basis of homeostatic
control of REM sleep. Although REM sleep deprivation has long been
used for REM sleep experiments, the neural mechanisms under-
lying the homeostatic control of REM sleep remains elusive. A
closed-loop experiment with optogenetic manipulations to manip-
ulate the duration of REM sleep may  be a  promising approach to
address this issue  without causing stress compared to  conventional
approaches. This closed-loop approach will also offer an opportu-
nity to explore the functions of REM sleep.
The forth issue is  to decipher the dynamics of neural ensembles
for REM sleep regulation. Since the identification of REM-on and
–off neurons in  1970s, it is still unclear how these functionally dis-
tinct cell populations interact with each other. Monitoring neural
ensembles across hypothalamic/brainstem areas and incorporat-
ing these findings with computational approaches will provide
promising insights into the neural dynamics of REM sleep. Although
realistic computational models with spiking neurons are also worth
developing, quantitative descriptions of the electrophysiology and
anatomy are still scarce. Efforts similar to those for cortical circuits
are unmet needs in  this field.
The final and most fundamental issue is to  understand the
function of REM sleep. Why did REM sleep emerge only in mam-
mals, birds and some reptiles? Why does the duration of  REM
sleep decrease as the brain matures? What are the differences in
memory-related neural processes between REM and NREM sleep?
And why  do we dream? Although several influential hypotheses
have been proposed during the 1960s to  80s (Crick and Mitchison,
1983; Hobson and McCarley, 1977; Davenne and Adrien, 1984;
Roffwarg et al., 1966), they have not  been fully tested experimen-
tally. Accumulating evidence suggests the role of REM sleep in
memory consolidation (Boyce et al., 2017; Stickgold and Walker,
2013; Poe, 2017; Sara, 2017; Rasch and Born, 2013; Siegel, 2001;
C. Héricé et al. /  Neuroscience Research 140 (2019) 77–92 87
Peever and Fuller, 2017). While controversy surrounding this
hypothesis has persisted, a  recent study used optogenetics in mice
to demonstrate that theta rhythm during REM sleep plays a  causal
role in spatial and contextual memory consolidation (Boyce et al.,
2016). Another recent imaging study showed that newly formed
synapses of cortical layer 5 pyramidal cells can be selectively
eliminated and maintained via dendritic calcium spike-dependent
mechanisms during REM sleep (Li et al., 2017). Thus, with the
advent of recent revolutionary technologies, it is now an exciting
period to revisit early hypotheses for a  better understanding of REM
sleep.
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BNST: bed nucleus of the stria terminalis
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DA: dopamine
DMH: dorsomedial hypothalamus
DpMe: deep mesencephalic reticular nucleus
DRN: dorsal raphe nucleus
EEG: electroencephalogram
eVLPO: extended area of the ventrolateral preoptic area
GABA: -aminobutyric acid
GiA: alpha gigantocellular nucleus




LDT: laterodorsal tegmental nucleus
LPB: lateral parabrachial nucleus
LPGi: lateral paragigantocellular nucleus
MCH: melanin-concentrating hormone
MPB: medial parabrachial nucleus
OH: orexin/hypocretin
PAG: periaqueductal gray
PPT: pedunculopontine tegmental nucleus
REM: rapid eye  movement
RMg: raphe magnus
RPA: nucleus raphe pallidus
SLD: sublaterodorsal nucleus
vlPAG: ventrolateral periaqueductal gray
VLPO: ventrolateral preoptic area
vM: ventral medulla
vmM: ventromedial medulla
VTA: ventral tegmental area
ZI: zona incerta
